Segregated early weaning

Journal of Swine Health and Production

Volumn 5, Issue 5, 1997, Pages 195-198

  Fangman, Thomas J ^a   Tubbs, Roderick C ^b  

^a UNIVERSITY OF MISSOURI   (United States)

^b Green River Swine Consultation ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 3142601512     PISSN: 1537209X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Alexander TJL, Thornton K, Boon G, Lysons RJ, Gush AF. Medicated early weaning to obtain pigs free from pathogens endemic in the herd of origin. Vet Rec. 1980; 106:114-119.
2. Connor J. Elimination of specific agents from herds: Elimination by medication. Proc MN Swine Conf Vet. 1992; 151-157.
3. Clark LK, Hill MA, Kniffen TS, VanAlstein W, Stevenson G, Meyer KB, Wu CC, Scheidt AB, Know K, Albregts S. An evaluation of the components of medicated early weaning. SHAP. 1994; 2(3): 5-11.
4. Dritz S. Application of segregated early weaning technology in the commercial swine industry. Comp Cont Ed. May 1994; 677-685.
5. Stanley TS. Impact of immune system activation on growth and nutrient needs of pigs, Proc Pork Summit. Orlando, Florida, April 1994; 1-7.
6. Harris DL. Isolated weaning. Large An Vet; 1990; May/June:10-12.
7. Dufresne L. Observations and results in different segregated early weaning and multiple-site production systems. Proc. AD Leman Swine Conf. St. Paul, Minnesota. 1995; 170-173.
8. Whitehair CK, Thompson CM. Observations on raising disease-free swine. JAVMA. 1956; 128:94-101.
9. Trexler PC. The gnotobiotic-review and future. Bio-med Purview. 1961; 1:7-10.
10. Harris DL Medicated early weaning, Proc SE Swine Pract Conf. Raleigh, North Carolina. 1993;1-19
11. Curtis J, Bourne FJ. Immunoglobulin quantitation in sow serum, colostrum, and milk and the serum of young pigs, Biochem Biophys Acta. 1971; 236:319.
12. Curtis J, Bourne FJ. Half lives of immunoglobulins IgG, IgA, IgM in the serum of newborn pigs. Immunology, 1973; 24:147.
13. Wilson MR. Role of immunity in the control of neonatal colibacilosis in pigs,JAVMA. 1972; 160:586.
14. Clark LK. SEW-control or elimination of Mycoplasma byopnemoniae and viruses. Swine Dis Conf for Swine Pract. Ames, Iowa. November, 1995; 69-73.
15. Moore C. Using high-health technology in a modern production system. Proc AD Leman Swine Conf. St Paul, Minnesota. 1995; 15-16.
16. Dee SA, Morrison RB, Joo HS. Eradicating porcine reproductive and respiratory syndrome (PRRS) virus using two-site production and nursery depopulation. SHAP. 1993; 1(5):20-23.
17. Clifton-Hadley FA, Alexander T, Enright MR. The epidemiology, diagnosis, treatment and control of Streptococcus suis type 2 infection, Proc AASP Annual Meeting. 1986; 473-491.
18. Wiseman BS, Morrison RB, Dial CD, Molitor TW, Pijoan C, Bergland M. Influence of weaning age on pathogen elimination and growth performance of commingled pigs derived by medicated early weaning (MEW),Proc 12th IPVS Cong. 1992; 500.
19. Klasing KC. Interactions between nutrition and immunity, Proc AD Leman Swine Conf. 1994; 35-39.
20. Bistrain BR, Schwartz J, Istfan NW. Cytokines, muscle proteolysis, and the catabolic response to infection and inflammation. Proc Soc Exp Bio and Med. 1992; 220-223.
21. Bagby GJ, Lang CII, Skrepnik N, Spitzer JJ. Attenuation of glucose metabolic changes resulting from TNF: Administration by adrenergic blockade. Am J Physiol, 1992;R628-R635.
22. Williams NE. Impact of genetic and environmental factors on the growth of the young pig, Proc AASP Annual Meeting. 1994;185-190.
23. Kelley KW, Kent S, Dantzer R. Why sick animals don't grow: An immunological explanation, Growth of the Pig, GR Hollis, ed. CAB International publishing, 1993;119-132.
24. Dantzer R, Kelly KW. Stress and immunity. An integrated view of relationships between the brain and the immune system. Life Sci, 1989;1995-2005.
25. Merril JE, Chen ISY. HIV-1, glial cells, and cytokines in the AIDS nervous system disease. FASEB J. 1991; 5:2391-2397.
26. Arkins WP, Dantzer R, Kelley KW. Somatolactins, somatomedins, and immunity. J Dairy Sci. 1993; 76:2437-2450.
27. Mallard BA, Wilkie BN, Kennedy BW. Genetic improvement of immune response and disease resistance in pigs. Proc MN Swine Vet Conf. 1991;91-95.
28. Wiseman B, Molitor T, White M, Morrison R, Dial G. Health and immunological aspects of early weaning. Proc AASP Annual Meeting. 1994;191-193.
29. Pijoan C. Disease of high-health pigs: Some ideas on pathogenesis. Proc AD Leman Swine Conf. St Paul Minnesota. 1995; 16-17.
30. Dee SA. Apparent prevention of Mycoplasma byopneumoniae infection in growing pigs with a low-cost modified-medicated-early-weaning program. SHAP. 1994; 2 (6): 7-12.
31. Tsay CE, Weng CN, Pang F, Chen PC. A comparison of the immune system and physiological organs between SPF and conventional pigs. Rept Pig Res Inst. Taiwan, 1989; 69-74.
32. Waxler GL, Drees DT. Comparison of body weights, organ weights and histological features of selected organs of gnotobiotic, conventional and isolator reared contaminated pigs.' Can J Comp Med. 1972; 36:265-274.
33. Rejnek J, Travnick J, Kostka J, Stertzl J, Land A. Study of the effect of antibodies in the intestinal tract of germ-free baby pigs. Folia Microbiol. (Prague) 1968; 13:36.
34. Miniats DP, Mitchell L, Barnum DA. Response of gnotobiotic pigs to Escherichia coli. Can J Comp Med. 1970; 34:269
35. Kohler EM, Bohl EH. Studies of Escherichia coli in gnotobiotic pigs. III. Evaluation of orally administered specific antisera. Can J Comp Med Vet Sci. 1966; 30:233.
36. Pierce JL, Cromwell GL, Lindeman MD, Coffey RD. Assessment of spray-dried porcine plasma on performance of early-weaned pigs. Proc Anin Sci Anim Sci, Midwestern section. Des Moines, Iowa. 1995; 81
37. Muirhead MR. The high-health status herd. Pig Vet Soc J. 1989; 22:38-50.
38. Fangman TJ, Tubbs RC, Becker BA., Evaluation of SEW in field and controlled trials investigating performance, immunological indicators (CD4, CD8), and herd health status. SHAP. 1996; 4 (5): 217-222.